SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The Revenue for the quarter ended  December 2025 of Rs. 16422.40 millions grew by 16.79 % from Rs. 14060.90 millions.Net Profit recorded in the quarter ended December 2025 rise to 33.40% to Rs. 1144.70  millions  compared to R. 858.10 millions in corresponding previous quarter.Operating Profit saw a handsome growth to 2823.40 millions from 1952.90 millions in the quarter ended December 2025.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202512 202412 % Var 202512 202412 % Var 202503 202403 % Var
Sales 16422.40 14060.90 16.79 49326.50 44620.00 10.55 60326.30 58740.60 2.70
Other Income 107.30 154.60 -30.60 300.10 346.60 -13.42 478.90 313.20 52.91
PBIDT 2823.40 1952.90 44.57 8186.70 7654.10 6.96 9492.70 10298.40 -7.82
Interest 216.50 217.90 -0.64 671.00 527.60 27.18 764.70 544.70 40.39
PBDT 2184.50 1735.00 25.91 7093.30 7255.20 -2.23 8856.70 9753.70 -9.20
Depreciation 796.70 696.90 14.32 2286.80 2084.90 9.68 2770.80 2711.40 2.19
PBT 1387.80 1038.10 33.69 4806.50 5170.30 -7.04 6085.90 7042.30 -13.58
TAX 243.10 180.00 35.06 833.00 892.50 -6.67 1054.70 377.50 179.39
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 1144.70 858.10 33.40 3973.50 4277.80 -7.11 5031.20 6664.80 -24.51
Equity 393.10 393.10 0.00 393.10 393.10 0.00 393.10 393.10 0.00
PBIDTM(%) 17.19 13.89 23.79 16.60 17.15 -3.25 15.74 17.53 -10.25

Alembic Pharma Share Price

755.00 -29.95 (-3.82%)
20-Apr-2026 15:21 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1667.00
Dr. Reddys Lab 1231.75
Cipla 1228.35
Zydus Lifesciences 936.00
Lupin 2327.15
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×